Divisas / ANIP
ANIP: ANI Pharmaceuticals Inc
93.50
USD
0.97
(1.05%)
El tipo de cambio de ANIP de hoy ha cambiado un 1.05%. En este caso, el precio mínimo en el mercado ha alcanzado 91.97, mientras que el máximo ha alcanzado 93.72.
Siga la dinámica de la pareja de divisas ANI Pharmaceuticals Inc. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ANIP News
- J&J Ends Imaavy Development in Rheumatoid Arthritis Post Study Failure
- Ani Pharmaceuticals stock hits 52-week high at 93.0 USD
- Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?
- ANI Pharmaceuticals (ANIP) is a Great Momentum Stock: Should You Buy?
- IOVA Stock Drops 6% on $350M Common Stock Offering
- Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"
- GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo
- Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
- ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?
- Ani Pharmaceuticals stock hits 52-week high at 90.43 USD
- Axon, DoorDash, Harmony Gold Among Today's Best Stocks To Buy And Watch: Check Out New Names Added To IBD Stock Lists
- ANI Pharmaceuticals stock price target raised to $77 from $65 at Truist Securities
- ANI (ANIP) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
- ANI Pharmaceuticals stock price target raised to $93 from $84 at H.C. Wainwright
- ANI Pharmaceuticals stock price target raised to $93 from $84 at H.C. Wainwright
- Ani Pharmaceuticals stock hits 52-week high at 77.86 USD
- ANI Pharma earnings beat by $0.40, revenue topped estimates
- ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass Estimates
- Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates
- Constellation Software, Under Armour, Muenchener Rueckver set to report Friday
- How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
- Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
- CG Oncology wins Delaware jury trial against ANI Pharmaceuticals
- ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release
Rango diario
91.97
93.72
Rango anual
52.50
93.72
- Cierres anteriores
- 92.53
- Open
- 93.03
- Bid
- 93.50
- Ask
- 93.80
- Low
- 91.97
- High
- 93.72
- Volumen
- 705
- Cambio diario
- 1.05%
- Cambio mensual
- 48.13%
- Cambio a 6 meses
- 53.88%
- Cambio anual
- 48.60%
30 agosto, sábado